Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;12(7):922-927.
doi: 10.1002/mdc3.70012. Epub 2025 Feb 19.

Magnetic Resonance-Guided Focused Ultrasound Treatment for Essential Tremor: A Single-Center Experience

Affiliations

Magnetic Resonance-Guided Focused Ultrasound Treatment for Essential Tremor: A Single-Center Experience

Victor S Hvingelby et al. Mov Disord Clin Pract. 2025 Jul.

Abstract

Background: Essential tremor is the most common hyperkinetic movement disorder. Magnetic resonance imaging-guided focused ultrasound (MRgFUS) has emerged as second-line therapy.

Objective: The aim was to obtain the results of the first 108 patients treated with MRgFUS in Denmark.

Methods: Data were entered in a quality assurance database at baseline and 3, 6, and 12 months. Clinician- and patient-rated treatment efficacy was evaluated using the Fahn-Marin-Tolosa (FMT) scale and the Patient Global Impression of Change.

Results: A total of 108 persons have currently been treated. Tremor improved by a total mean 6.39 points (95% confidence interval [CI]: 5.01;7.76, P < 0.00001) and 9.63 points (95% CI: 7.60;11.66, P < 0.00001), 10.42 (95% CI: 9.06;11.79, P < 0.00001), and 26.45 (95% CI: 22.46;30.43, P < 0.00001) for FMT parts A, B, and C, respectively, at 3 months. Side effects occurred in 65.7% of patients at 3 months and 33.7% at 12 months.

Conclusion: Our findings are in line with existing evidence. Questions regarding persistence of gait- and balance-related side effects remain.

Keywords: essential tremor; focused ultrasound; magnetic resonance imaging.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Changes in assessor‐ and patient‐rated outcomes across the first year after treatment. (A) The changes between baseline, 3 months, and 12 months according to the Fahn–Marin–Tolosa (FMT) scale. (B) The changes between baseline, 3 months, 6 months, and 12 months according to the patient‐rated Quality of Life in Essential Tremor (QUEST) scale and (C) the Patient Global Impression of Change (PGIC) at 1, 3, 6, and 12 months.
FIG. 2
FIG. 2
Changes in the use of medication after treatment in the first 12 months after treatment. (A) The frequency of ingestion of common antitremor medications. (B) The percentage of patients taking and not taking antitremor medications, respectively, at baseline, 3 months, and 12 months. (C) The mean of individual medication usage as a percentage of use at baseline after 3 months where dose at baseline is set at 100%.

References

    1. Deuschl G, Bain P, Brin M, Agid Y, Benabid L, Benecke R, et al. Consensus statement of the Movement Disorder Society on tremor. Mov Disord 1998;SUPPL. 3:2–23. - PubMed
    1. Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 2018;33(1):75–87. 10.1002/mds.27121. - DOI - PMC - PubMed
    1. Louis ED, Barnes L, Albert SM, Cote L, Schneier FR, Pullman SL, Yu Q. Correlates of functional disability in essential tremor. Mov Disord 2001;16(5):914–920. 10.1002/mds.1184. - DOI - PubMed
    1. Meng Y, Huang Y, Solomon B, Hynynen K, Scantlebury N, Schwartz ML, et al. MRI‐guided focused ultrasound thalamotomy for patients with medically‐refractory essential tremor. J Vis Exp 2017;130:e56365. 10.3791/56365. - DOI - PMC - PubMed
    1. Hino S, Maki F, Yamaguchi T, Kaburagi M, Nakano M, Iwamuro H, et al. Effectiveness and safety of MR‐guided focused ultrasound thalamotomy in patients with essential tremor and low skull density ratio: a study of 101 cases. J Neurosurg 2024;141:1–9. 10.3171/2023.11.Jns231799. - DOI - PubMed

LinkOut - more resources